This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
milla1cf Mon, 03/18/2024 - 08:00 March 18, 2024 — The Smidt Heart Institute at Cedars-Sinai recently became one of four institutions in the U.S. and the first on the West Coast to use a new device aimed at lowering bloodpressure in patients with difficult-to-treat hypertension. Florian Rader, MD, MSc.
In general, the more calcified or fibrous a plaque is, the less dangerous it is, as it is less likely to rupture and cause a heartattack. Fatty or necrotic plaque is often described as ‘vulnerable’ plaque, with the vulnerability being related to the risk of a heartattack. Springer, Cham. Am J Cardiol.
These groundbreaking developments offer a paradigm shift in the management of resistant hypertension, especially when it is extremely difficult to achieve bloodpressure control through conventional means, such as lifestyle modifications and various drug therapies.
Managing bloodpressure. mmol/l (197 mg/dl) with normal bloodpressure who is a little overweight, does not smoke or have diabetes and has a family history of heart disease. Suddenly, a 43% chance of a heartattack or stroke becomes a 19% risk. Eur Heart J. Being active. Good nutrition.
If the amount of fluid is large or there is a rapid increase in the rate of fluid collection, the compression of the heart prevents its proper filling. An unfilled heart is not able to pump out blood well and the bloodpressure falls. This serious condition is known as cardiac tamponade.
If the pump is unable to pump blood out (either because it is defective or because something is making it more difficult to pump blood out in some way) then less blood goes around and this can damage our vital organs and be dangerous. So what tests tell us about the heart as a pump?
If the inflammation spreads to the surface of the heart itself, it is termed myopericarditis. About 5% of patients who present to A+E with chest pain which is not deemed to be a heartattack or angina are ultimately diagnosed with pericarditis. Also recent cardiac surgery and a recent heartattack can present with pericarditis.
The mistake most people make when it comes to heart disease is thinking that when someone has a heartattack that, the condition of ‘heart disease’ just appeared. Heartattacks present suddenly. But heart disease presents slowly. But so do ‘Young People’ Here’s why.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content